Items tagged with Access
Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment (post with simple image)
120,707 people signed petitions urging the corporation to drop the price.
Treatment Action Group statement on bedaquiline unaffordability (post with simple image)
Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.
TB CAB Statement (post with simple image)
TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction
TAG policy brief: Advancing Access through Market Interventions (post with simple image)
Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down
Public investment in bedaquiline up to five-fold that of Johnson & Johnson (post with simple image)
PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.
Page 66 of 66 · Total posts: 0←First 65 66